We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$32.1B
AUM Growth
+$306M
Cap. Flow
-$1.05B
Cap. Flow %
-3.25%
Top 10 Hldgs %
5.21%
Holding
3,026
New
153
Increased
1,158
Reduced
1,530
Closed
143

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$39.8M
2
COO icon
Cooper Companies
COO
+$29.5M
3
MTD icon
Mettler-Toledo International
MTD
+$29.1M
4
ALB icon
Albemarle
ALB
+$25M
5
LNT icon
Alliant Energy
LNT
+$23.9M

Sector Composition

Rank Sector Weight
1 Technology 12.43%
2 Healthcare 11.67%
3 Financials 11.21%
4 Industrials 10.39%
5 Consumer Discretionary 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHN icon
2851
Cohen & Co
COHN
$46.7M
$13K ﹤0.01%
1,218
-19
-2% -$208
EGY icon
2852
Vaalco Energy
EGY
$564M
$13K ﹤0.01%
13,634
-202
-1% -$199
GALT icon
2853
Galectin Therapeutics
GALT
$200M
$13K ﹤0.01%
+11,639
New +$20.7K
AUMN
2854
DELISTED
Golden Minerals Company
AUMN
$13K ﹤0.01%
+703
New +$15K
TST
2855
DELISTED
TheStreet, Inc.
TST
$13K ﹤0.01%
1,171
-19
-2% -$221
GEF.B icon
2856
Greif Class B
GEF.B
$4.11B
$12K ﹤0.01%
195
+14
+8% +$764
WSTL
2857
DELISTED
Westell Technologies Inc
WSTL
$12K ﹤0.01%
+5,906
New +$14.4K
MSN icon
2858
Emerson Radio
MSN
$7.99M
$11K ﹤0.01%
+10,918
New +$8.7K
UAMY icon
2859
United States Antimony
UAMY
$907M
$11K ﹤0.01%
23,425
-275
-1% -$100
SEEL
2860
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
CRVP
2861
DELISTED
Crystal Rock Holdings, Inc.
CRVP
$10K ﹤0.01%
11,401
-185
-2% -$145
CYTR
2862
DELISTED
CytRx Corp
CYTR
$9K ﹤0.01%
2,571
+112
+5% +$513
IMUC
2863
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$9K ﹤0.01%
1,984
+1,038
+110% +$6.68K
OGEN icon
2864
Oragenics
OGEN
$2.39M
$8K ﹤0.01%
+1
New +$12K
AGPU
2865
Axe Compute Inc
AGPU
$103M
$8K ﹤0.01%
+1
New +$10.6K
SSKN
2866
DELISTED
Strata Skin Sciences
SSKN
$8K ﹤0.01%
+303
New +$9.64K
DSS icon
2867
DSS Inc
DSS
$5.35M
$7K ﹤0.01%
18
GEVO icon
2868
Gevo
GEVO
$355M
$7K ﹤0.01%
35
MNKD icon
2869
MannKind Corp
MNKD
$1.17B
$7K ﹤0.01%
2,201
+114
+5% +$504
PRPO icon
2870
Precipio
PRPO
$39.6M
$7K ﹤0.01%
+3
New +$10.3K
ACHV icon
2871
Achieve Life Sciences
ACHV
$664M
$6K ﹤0.01%
5
-1
-17% -$1.59K
CRTN
2872
DELISTED
Cartesian, Inc.
CRTN
$6K ﹤0.01%
+10,025
New +$7.31K
SVRA icon
2873
Savara
SVRA
$1.09B
$5K ﹤0.01%
662
-7
-1% -$199
IDXG
2874
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$5K ﹤0.01%
+314
New +$8.68K
WGA
2875
DELISTED
AG&E Holdings Inc
WGA
$5K ﹤0.01%
19,899
-349
-2% -$97

Similar funds

Guggenheim Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Guggenheim Capital held 3,026 positions worth $32.1B, up 0.96% from $31.8B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Guggenheim Capital withdrew a net $1.05B in Q3 2016, closing 143 positions and reducing 1,530 holdings. Its most notable exit was DIAMOND RESORTS INTL, INC, an estimated $283M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Guggenheim Capital opened a new position in Fortive worth $39.8M.

  • Guggenheim Capital's largest Q3 2016 buy was Fortive: 1,239,033 shares worth $39.8M.
  • Guggenheim Capital added most to Cooper Companies in Q3 2016, an estimated $29.5M increase.
  • Guggenheim Capital's biggest Q3 2016 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $57.3M.
  • Guggenheim Capital fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $283M.
  • Guggenheim Capital's ten largest holdings make up 5.2% of its $32.1B portfolio in Q3 2016.
  • Guggenheim Capital opened 153 new positions and closed 143 in Q3 2016.
  • Guggenheim Capital's portfolio value rose 0.96% quarter-over-quarter to $32.1B.

Based on Guggenheim Capital's 13F filing for Q3 2016, filed 15 Nov 2016.